|Articles|May 31, 2010
AVMA revises biotechnology policy
Schaumburg, Ill. -- The American Veterinary Medical Association?s (AVMA) Executive Board revised its policy on ?Use of Biotechnology in Development of Drugs and Vaccines? in April.
Advertisement
Schaumburg, Ill.
Advertisement
-- The American Veterinary Medical Association’s (AVMA) Executive Board revised its policy on “Use of Biotechnology in Development of Drugs and Vaccines” in April.
The revisions officially recognize the importance of biotechnology in drug and vaccine development, revealing how biotechnology use can help enhance surveillance and evaluate new developments with a science-based approach.
The amended policy can be found
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on dvm360
1
Q&A with an emergency veterinarian on critical care and common ER misconceptions
2
Tornado (the dog) touches down at the emergency department
3
Every 30 extra minutes under anesthesia raises complication risk in brachycephalic patients, underscoring the importance of peri-anesthetic management
4
When veterinary partnerships work (and when they don’t)
5